Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Lee Johnson currently holds 45,727 shares of Global Blood Therapeutics, Inc. (GBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Lee Johnson has been a net seller of GBT stock. They have purchased $0 and sold $108.3K worth of shares.
David Lee Johnson's most recent insider trade was on Feb 23, 2026, when they sold 2,579 shares at $41.98 per share.
David Lee Johnson serves as Executive at Global Blood Therapeutics, Inc. (GBT). They have executed 51 insider transactions totaling $108.3K over their tenure at the company.
David Lee Johnson holds the position of Executive at Global Blood Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
David Lee Johnson has shown a selling trading pattern, with $0 in total purchases and $108.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Lee Johnson was on Aug 1, 2020, when they sold $176.7K worth of GBT shares. This transaction involved 2,618 shares at $67.48 per share.
David Lee Johnson currently owns 45,727 shares of Global Blood Therapeutics, Inc. (GBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Lee Johnson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Lee Johnson has 51 Form 4 filings on record as an insider at Global Blood Therapeutics, Inc..
Set alerts for David Lee Johnson and 40,000+ other insiders.